Stan Naydin, MD; and Michelle L. Dougherty, MD, FAAN
November/December 2018—Implantable devices are an emerging option for patients with medically refractory epilepsy who are not surgical candidates.
Graham R. Huesmann, MD, PhD; and Riley Bove, MD
November/December 2018—Research on the interaction between hormones and seizures supports the importance of helping patients manage stress.
Elizabeth Londen, PhD; Thomas Preston, PhD, ABBP-CN; and Brian K. Lebowitz, PhD, ABBP-CN
November/December 2018—There are evidence-based tools for staying sharp throughout the lifespan.
Cassandra Kazl, MD; and Daniel Friedman, MD, MSc
November/December 2018—Seizure detection and alerting devices hold promise for preventing sudden death in epilepsy.
Patricia K. Coyle, MD, FAAN, FANA
November/December 2018—There is clear evidence for promoting wellness practices to all patients with neurologic disorders.
Wednesday, November 28, 2018—Brief cognitive tests are useful screening tools for dementia in the primary care setting; however, a study published in the journal Neurology Clinical Practice show…
Wednesday, November 14, 2018—A prospective, multi-center clinical study of 42 patients with brain lesions that recurred after stereotactic radiosurgery (SRS) for metastatic brain tumors showed p…
Monday, November 05, 2018—The Food and Drug Administration (FDA) has approved an oral film clobazam (Sympazan; Aquestive Therapeutics, Warren, NJ) for the adjunctive treatment of seizures in patients, …
